Infertility Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2019

Posted by priya saraf on June 5th, 2019

Infertility Drugs Market – Insights

Infertility is a global health issue as its affects both men and women. Infertility in females occur due to increasing age, polycystic ovarian syndrome (PCOS), obesity, and multiple miscarriages whereas in males infertility occur due to erectile dysfunction, low sperm count, abnormal sperms, etc. Increasing prevalence of infertility is expected to propel demand for the infertility drugs.According to World Health Organization (WHO) 2012 report, infertility affects one out of four couples in emerging economies.

Many researchers are working towards finding an efficient treatment for the infertility. For instance, in 2018 at Ben-Gurion University (BGU), Israel researchers were developing a new, single-dose infertility treatment based on a new compound. The new treatment, developed by the BGU researchers, stimulates the expression of the telomerase and re-elongates the telomeres, protecting the cells from damage The global infertility drugs market size was valued at US$ 3.8 billion in 2017, and is expected to witness a CAGR of 5.8% over the forecast period (2019 – 2026).

Request A Sample Copy:

Increasing Research & Development for More Effective Treatment with Lesser Side-Effects to Reduce Infertility is expected to Drive Growth of the Infertility Drugs Market

The infertility drugs market size is expected to witness significant growth, owing to the rising research and developmental studies for more effective treatment to achieve pregnancy and live births. For instance, in 2014, a team of researchers at National Institutes of Health’s (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) found that women treated with Letrozole have high rates of ovulation and live births than women treated with the standard drug, Clomiphene. Furthermore, among women who received Letrozole, 27.5% of them eventually had a live birth and women who received clomiphene, only 19.1% them experienced a live birth. The cumulative ovulation rate was higher for the Letrozole group, with ovulation occurring 61.7% of the time, and the women in the clomiphene group ovulated 48.3% of the time.

Infertility Drugs Market - Regional Insights

On the basis of region, the global infertility drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global infertility drugs market size, owing to the rising number of new Food and Drug Administration (FDA) infertility drug approvals over the forecast period. For instance, in 2018, Zydus Cadila launched generic Vardenafil Hydrochloride tablets used for the treatment of erectile dysfunction in the U.S. The company has launched the tablets in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg.

Asia Pacific infertility drugs market size is expected to foresee a rapid growth in the market, owing to rise in research and development activities for better reproductive health. For instance, in 2018, Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) announced a long-term collaboration to advance basic and translational research in reproductive medicine through the development of novel product candidates and therapeutic strategies.

Infertility Drugs Market - Competitive Landscape

Key players operating in the global infertility drugs market include Merck & Co., Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., Abbott Laboratories, Bayer AG, and Zydus Pharmaceuticals.

Click To Read More On DiscrInfertility Drugs Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:


Coherent Market Insights

1001 4th Ave,


Seattle, WA 98154

Tel: +1-206-701-6702

Like it? Share it!

priya saraf

About the Author

priya saraf
Joined: May 23rd, 2019
Articles Posted: 166

More by this author